Search Login Register

Toxoplasmosis Summary

Description: The acquired form of infection by Toxoplasma gondii in animals and man.

Also Known As: Infection, Toxoplasma gondii; Infections, Toxoplasma gondii; Toxoplasma gondii Infections; Toxoplasmoses; Toxoplasma gondii Infection

Networked: 2733 relevant articles (161 outcomes, 268 trials/studies) for this Disease

Key Drugs and Agents for Toxoplasmosis

Efficacy Chart >>
Drugs and Important Biological Agents (IBA) related to treatments:
  1. Pyrimethamine (Daraprim) : 23 outcomes 8 studies in 160 results : FDA 2
  2. Antigens : 12 outcomes 37 studies in 291 results : IBA
  3. Sulfadiazine (Sulphadiazine) : 11 outcomes 3 studies in 71 results : FDA 8
  4. DNA (Deoxyribonucleic Acid) : 10 outcomes 7 studies in 90 results : IBA
  5. Clindamycin (Cleocin) : 10 outcomes 4 studies in 46 results : FDA 19 Generic
  6. Atovaquone (Mepron) : 10 outcomes 3 studies in 37 results : FDA 3
  7. Azithromycin (Zithromax) : 9 outcomes 1 study in 20 results : FDA 39 Generic
  8. Immunoglobulin G (IgG) : 7 outcomes 51 studies in 361 results : IBA
  9. Trimethoprim-Sulfamethoxazole Combination (Co-Trimoxazole) : 7 outcomes 5 studies in 69 results : FDA 6 Generic
  10. Proteins (Proteins, Gene) : 7 outcomes 4 studies in 50 results : IBA
Show All >>

Diseases Related to Toxoplasmosis

  1. Acquired Immunodeficiency Syndrome (AIDS)
  2. Infection
  3. Cysts
  4. Pneumocystis Pneumonia (Pneumocystis carinii Pneumonia)
  5. Malaria
Show All >>

Key Therapies for Toxoplasmosis

Efficacy Chart >>
  1. Transplants (Transplant) : 4 outcomes 1 study in 79 results
  2. Drug Therapy (Chemotherapy) : 3 outcomes 3 studies in 45 results
  3. Transplantation (Transplant Recipients) : 2 outcomes 2 studies in 95 results
  4. Aftercare (After-Treatment) : 2 outcomes in 14 results
  5. Highly Active Antiretroviral Therapy (HAART) : 1 outcome 1 study in 17 results
Show All >>

CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2016 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.